United Kingdom Cancer Diagnostics Market, By Product (Consumables v/s Instruments), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User (Hospitals & Clinics, Diagnostic Laborato

United Kingdom Cancer Diagnostics Market, By Product (Consumables v/s Instruments), By Technology (IVD Testing, Imaging, Biopsy), By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027

United Kingdom cancer diagnostics market is expected to witness robust growth in the forecast period. Cancer diagnostics is a process of identifying different proteins, biomarkers, or any other signs that can reveal the presence of a cancerous tumor in the body. Diagnostic testing is a crucial process that can validate or eliminate the existence of an illness and monitor the stage of the disease. It helps the healthcare professionals to decide the course of action and predict and review the treatment outcomes. The diagnostic procedures which help the patients to identify cancer are laboratory tests, surgery, genetic testing, tumor biopsy, imaging, or endoscopic testing. Factors such as the rise in consumer awareness about the benefits of early diagnosis and treatment and the increase in the number of diagnostic laboratories are primarily driving the growth of the United Kingdom cancer diagnostics market in the forecast period. Increased adoption of unhealthy eating habits and a sedentary lifestyle has escalated the occurrence of cancer across the country.

United Kingdom cancer diagnostics market is segmented into product, technology, application, end user, regional distribution, and competitive landscape.

Based on product, the market is bifurcated into consumables and instruments. Consumables are dominating the market and are expected to maintain their dominance over the next five years owing to the rise in the adoption of consumables for cancer diagnostics and high-end investments for research and development activities. The launch of technologically advanced kits & reagents in the market and the growing old age population are the other prominent drivers expected to drive the segment demand.

Based on technology, the market is divided into IVD testing, imaging, and biopsy. Imaging technology is expected to account for a significant market share in the forecast period. By using imaging technology, healthcare professionals can easily decide the course of action. The constant rise in the number of cancer patients is accelerating the demand for imaging modalities in the country.

GE Healthcare UK Limited, Becton, Dickinson U.K. Limited, Roche Diagnostics UK, Abbott Laboratories Limited, Fujifilm Healthcare UK Limited, Hologic (UK) Limited, Agilent Technologies UK Limited, are the major market players operating in the United Kingdom cancer diagnostics market.

Years considered for this report:

Historical Years: 2017-2020

Base Year: 2021

Estimated Year: 2022E

Forecast Period: 2023F–2027F

Objective of the Study:

• To analyze the historical growth in the market size of the United Kingdom Cancer diagnostics market from 2017 to 2021.
• To estimate and forecast the market size of United Kingdom Cancer diagnostics market from 2022E to 2027F and growth rate until 2027F.
• To classify and forecast the United Kingdom Cancer diagnostics market based on product, technology, application, end user, region, and company.
• To identify the dominant region or segment in the United Kingdom Cancer diagnostics market.
• To identify drivers and challenges for the United Kingdom Cancer diagnostics market.
• To examine competitive developments such as expansions, mergers & acquisitions, etc., in the United Kingdom Cancer diagnostics market.
• To identify and analyze the profiles of leading players operating in the United Kingdom Cancer diagnostics market.
• To identify key sustainable strategies adopted by market players in United Kingdom Cancer diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of companies across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the comapnies, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the country.

TechSci Research calculated the market size of the United Kingdom Cancer diagnostics market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Cancer diagnostics service providers
• Market research and consulting firms
• Government bodies such as regulating authorities and policy makers
• Organizations, forums, and alliances related to Cancer diagnostics

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, vendor and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, United Kingdom cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• United Kingdom Cancer Diagnostics Market, By Product:
• Consumables
• Instruments
• United Kingdom Cancer Diagnostics Market, By Technology:
• IVD Testing
• Imaging
• Biopsy
• United Kingdom Cancer Diagnostics Market, By Application:
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Others
• United Kingdom Cancer Diagnostics Market, By End User:
• Hospitals & Clinics
• Diagnostic Laboratories
• Others
• United Kingdom Cancer Diagnostics Market, By Region:
• London
• Southeast
• East Anglia
• Scotland
• Southwest
• East Midlands
• Yorkshire & Humberside
• Rest of United Kingdom

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in United Kingdom cancer diagnostics market.

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights